{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T05:59:17Z","timestamp":1784872757576,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T00:00:00Z","timestamp":1760572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Manipal Academy of Higher Education, Manipal"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatitis E represents an increasingly significant yet often overlooked public health issue in India, contributing substantially to both sporadic hepatitis cases and widespread waterborne outbreaks. Hepatitis E virus (HEV) is the foremost cause of acute viral hepatitis (AVH) in India and spreads primarily through contaminated water. Genotype-specific differences in transmission routes, ranging from enteric routes in developing regions to zoonotic routes in industrialized settings, underscore the complexity of its epidemiology. Vulnerable populations such as pregnant women, animal handlers, and immunocompromised individuals face a markedly increased risk of severe disease outcomes, including fulminant hepatic failure and chronic infection, in cases of coinfection with hepatitis B virus.<\/jats:p>\n                  <jats:p>This comprehensive review delves into Indian epidemiological trends, clinical features, diagnostic approaches, and current management options for HEV. While most infections are self-limiting, ribavirin has shown efficacy in select high-risk populations. However, the absence of an approved vaccine in India remains a critical gap in preventive strategies. Emerging therapeutics and vaccine candidates are currently in various stages of development. However, challenges such as the genetic diversity of HEVs, lack of long-term efficacy data, and limited public awareness hinder progress.<\/jats:p>\n                  <jats:p>This review emphasizes the urgent need for strengthened national surveillance systems, improved water and sanitation infrastructure, and integrated public health policies tailored for high-risk groups. A multipronged approach that combines epidemiological vigilance, clinical preparedness, and policy-driven interventions is imperative to halt the silent transmission of hepatitis E in India.<\/jats:p>","DOI":"10.1007\/s15010-025-02661-2","type":"journal-article","created":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T07:48:25Z","timestamp":1760600905000},"page":"41-55","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The silent spread of Hepatitis E in India - from epidemiological insight to public health action: a comprehensive review"],"prefix":"10.1007","volume":"54","author":[{"given":"Snigdha","family":"Maity","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivam","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akila","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhi","family":"Ashtaputre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piya Paul","family":"Mudgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiranjay","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,16]]},"reference":[{"issue":"1","key":"2661_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1128\/CMR.00057-13","volume":"27","author":"N Kamar","year":"2014","unstructured":"Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116\u201338.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"2661_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2298\/VSP0303353D","volume":"60","author":"M Doki\u0107","year":"2003","unstructured":"Doki\u0107 M, Begovi\u0107 V, Raji\u0107-Dimitrijevi\u0107 R, Aleksi\u0107 R, Popovi\u0107 S. Hristovi\u0107 D. [Fulminant hepatitis B]. Vojnosanit Pregl. 2003;60(3):353\u201360.","journal-title":"Vojnosanit Pregl"},{"key":"2661_CR3","unstructured":"Girish V, Grant LM, Sharma B et al. Hepatitis E. [Updated 2025 Apr 6]. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532278\/"},{"issue":"10","key":"2661_CR4","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.3390\/ijerph10104507","volume":"10","author":"DM Yugo","year":"2013","unstructured":"Yugo DM, Meng XJ, Hepatitis. E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health. 2013;10(10):4507\u201333. https:\/\/doi.org\/10.3390\/ijerph10104507. PMID: 24071919; PMCID: PMC3823334.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"2661_CR5","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.sjbs.2021.09.003","volume":"29","author":"YE Raji","year":"2022","unstructured":"Raji YE, Toung OP, Taib NM, Sekawi ZB, Hepatitis E, Virus. An emerging enigmatic and underestimated pathogen. Saudi J Biol Sci. 2022;29(1):499\u2013512.","journal-title":"Saudi J Biol Sci"},{"issue":"22","key":"2661_CR6","doi-asserted-by":"publisher","first-page":"e00822","DOI":"10.1128\/JVI.00822-17","volume":"91","author":"S Nagashima","year":"2017","unstructured":"Nagashima S, Takahashi M, Kobayashi T, Tanggis; Nishizawa T, Nishiyama T, Primadharsini PP, Okamoto H. Characterization of the quasi-enveloped hepatitis E virus particles released by the cellular exosomal pathway. J Virol. 2017;91(22):e00822\u201317. https:\/\/doi.org\/10.1128\/JVI.00822-17. PMID: 28878075; PMCID: PMC5660490.].","journal-title":"J Virol"},{"key":"2661_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12879-024-09349-2","volume":"24","author":"UK Mirzaev","year":"2024","unstructured":"Mirzaev UK, Ouoba S, Ko K, et al. Systematic review and meta-analysis of hepatitis E Seroprevalence in Southeast Asia: a comprehensive assessment of epidemiological patterns. BMC Infect Dis. 2024;24:525. https:\/\/doi.org\/10.1186\/s12879-024-09349-2","journal-title":"BMC Infect Dis"},{"issue":"7","key":"2661_CR8","first-page":"79","volume":"11","author":"HM Noman","year":"2025","unstructured":"Noman HM, Arslan Sajid MM, Ali G, Amir MA, Akram J. Hepatitis-E outbreak in chad: a public health crisis amidst refugee influx from Sudan. World J Pharm Med Res. 2025;11(7):79\u201381.","journal-title":"World J Pharm Med Res"},{"issue":"12","key":"2661_CR9","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.3201\/eid2412.180937","volume":"24","author":"S Sridhar","year":"2018","unstructured":"Sridhar S, Yip CCY, Wu S, Cai J, Zhang AJX, Leung KH, et al. Rat hepatitis E virus as cause of persistent hepatitis after liver transplant. Emerg Infect Dis. 2018;24(12):2241\u201350.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"2661_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.virusres.2011.02.007","volume":"161","author":"MS Khuroo","year":"2011","unstructured":"Khuroo MS. Discovery of hepatitis E: the epidemic non-A, non-B hepatitis 30 years down the memory lane. Virus Res. 2011;161(1):3\u201314.","journal-title":"Virus Res"},{"key":"2661_CR11","doi-asserted-by":"crossref","unstructured":"Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomized, double-blind placebo-controlled, phase 3 trial. Lancet Lond Engl. 2010;376(9744):895\u2013902.","DOI":"10.1016\/S0140-6736(10)61030-6"},{"key":"2661_CR12","doi-asserted-by":"crossref","unstructured":"Koyuncu A, Mapemba D, Ciglenecki I, Gurley ES, Azman AS. Setting a course for preventing hepatitis E in low and lower-middle-income countries: a systematic review of burden and risk factors. InOpen Forum Infectious Diseases. 2021;8(6):ofab178. US: Oxford University Press.","DOI":"10.1093\/ofid\/ofab178"},{"issue":"12","key":"2661_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.4254\/wjh.v3.i12.285","volume":"3","author":"EH Teshale","year":"2011","unstructured":"Teshale EH, Hu DJ, Hepatitis E. Epidemiology and prevention. World J Hepatol. 2011;3(12):285\u201391. https:\/\/doi.org\/10.4254\/wjh.v3.i12.285. PMID: 22216368; PMCID: PMC3246546.","journal-title":"World J Hepatol"},{"issue":"3","key":"2661_CR14","first-page":"204","volume":"8","author":"SM Kadri","year":"2018","unstructured":"Kadri SM, Rehman SU, Rehana K, Benetou DR, Ahmad DF, Abdullah A, Chattu VK. Hepatitis A and E outbreak surveillance during 2015\u20132017 in Kashmir, india: is the water to blame? J Epidemiol Global Health. 2018;8(3):204\u20137.","journal-title":"J Epidemiol Global Health"},{"key":"2661_CR15","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.3389\/fmicb.2017.02396","volume":"8","author":"Y Nan","year":"2017","unstructured":"Nan Y, Wu C, Zhao Q, Zhou EM. Zoonotic hepatitis E virus: an ignored risk for public health. Front Microbiol. 2017;8:2396.","journal-title":"Front Microbiol"},{"issue":"10","key":"2661_CR16","first-page":"1127","volume":"5","author":"L Kamani","year":"2021","unstructured":"Kamani L, Padhani ZA, Das JK, Hepatitis E. Genotypes, strategies to prevent and manage, and the existing knowledge gaps. JGH Open Open Access J Gastroenterol Hepatol. 2021;5(10):1127\u201334.","journal-title":"JGH Open Open Access J Gastroenterol Hepatol"},{"key":"2661_CR17","doi-asserted-by":"publisher","unstructured":"Virhuez-Mendoza M, Ishijima K, Tatemoto K et al. Recent hepatitis E virus infection in wild boars and other ungulates in Japan. Viruses. 2025;17(4):524. https:\/\/doi.org\/10.3390\/v17040524. PMID: 40284967.","DOI":"10.3390\/v17040524"},{"key":"2661_CR18","doi-asserted-by":"publisher","unstructured":"Santos-Silva S, Hemnani M, Lopez-Lopez P et al. A systematic review of hepatitis E virus detection in camels. Veterinary Sciences. 2023;10(5):323. https:\/\/doi.org\/10.3390\/vetsci10050323. PMID: 37235406.","DOI":"10.3390\/vetsci10050323"},{"key":"2661_CR19","doi-asserted-by":"publisher","unstructured":"Zhang W, Li S, Shu X et al. A cross-species transmission of a camel-derived genotype 8 hepatitis E virus to rabbits. Pathogens. 2021;10(11):1374. https:\/\/doi.org\/10.3390\/pathogens10111374. PMID: 34832530.","DOI":"10.3390\/pathogens10111374"},{"issue":"5","key":"2661_CR20","first-page":"597","volume":"70","author":"SR Naik","year":"1992","unstructured":"Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ. 1992;70(5):597\u2013604. PMID: 1464145; PMCID: PMC2393368.","journal-title":"Bull World Health Organ"},{"issue":"28","key":"2661_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.15585\/mmwr.mm6428a3","volume":"64","author":"T Kumar","year":"2015","unstructured":"Kumar T, Shrivastava A, Kumar A, Laserson KF, Narain JP, Venkatesh S, Chauhan LS, Averhoff F. Viral hepatitis surveillance\u2013India, 2011\u20132013. MMWR Morb Mortal Wkly Rep. 2015;64(28):758\u201362. https:\/\/doi.org\/10.15585\/mmwr.mm6428a3. PMID: 26203629; PMCID: PMC4584861.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"209","key":"2661_CR22","first-page":"2161","volume":"4","author":"SS Negi","year":"2015","unstructured":"Negi SS, Barde PV, Pathak R, Gaikwad U, Das P, Bhargav A. An outbreak of hepatitis E virus in Raipur, Chhattisgarh, India in 2014: a conventional and genetic analysis. J Med Microb Diagn. 2015;4(209):2161\u20130703.","journal-title":"J Med Microb Diagn"},{"issue":"4","key":"2661_CR23","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3390\/v17040536","volume":"17","author":"R Daniel","year":"2025","unstructured":"Daniel R, Zelber-Sagi S, Barak M, Zuckerman E. The epidemiology of hepatitis E in Israel and potential risk factors: a cross-sectional population-based serological survey of hepatitis E virus in Northern Israel. Viruses. 2025;17(4):536.","journal-title":"Viruses"},{"key":"2661_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12985-020-01343-9","volume":"17","author":"C Wu","year":"2020","unstructured":"Wu C, Wu X, Xia J. Hepatitis E virus infection during pregnancy. Virol J. 2020;17:73. https:\/\/doi.org\/10.1186\/s12985-020-01343-9","journal-title":"Virol J"},{"issue":"1","key":"2661_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/21505594.2020.1865716","volume":"12","author":"YE Raji","year":"2021","unstructured":"Raji YE, Toung OP, Mohd Taib N, Sekawi ZB. A systematic review of the epidemiology of hepatitis E virus infection in South - Eastern Asia. Virulence. 2021;12(1):114\u201329. PMID: 33372843; PMCID: PMC7781573.","journal-title":"Virulence"},{"key":"2661_CR26","doi-asserted-by":"publisher","unstructured":"Nasir M, Wu GY. HEV and HBV dual infection: a review. J Clin Transl Hepatol. 2020;8(3):313\u2013321. https:\/\/doi.org\/10.14218\/JCTH.2020.00030. Epub 2020 Jul 3. PMID: 33083255; PMCID: PMC7562801.","DOI":"10.14218\/JCTH.2020.00030"},{"issue":"3","key":"2661_CR27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s12560-022-09530-3","volume":"14","author":"GR Takuissu","year":"2022","unstructured":"Takuissu GR, Kenmoe S, Ndip L, Ebogo-Belobo JT, Kengne-Nd\u00e9 C, Mbaga DS, et al. Hepatitis E virus in water environments: a systematic review and meta-analysis. Food Environ Virol. 2022;14(3):223\u201335.","journal-title":"Food Environ Virol"},{"key":"2661_CR28","doi-asserted-by":"crossref","unstructured":"Treagus S, Wright C, Baker-Austin C, Longdon B, Lowther J. The foodborne transmission of hepatitis E virus to humans. Food Environ Virol. 2021;13(1):127\u201345.","DOI":"10.1007\/s12560-021-09461-5"},{"key":"2661_CR29","doi-asserted-by":"crossref","unstructured":"Webb GW, Dalton HR. Hepatitis E: an expanding epidemic with a range of complications. Clin Microbiol Infect. 2020;26(7):828\u201332.","DOI":"10.1016\/j.cmi.2020.03.039"},{"issue":"37","key":"2661_CR30","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.3748\/wjg.v26.i37.5543","volume":"26","author":"AT Aslan","year":"2020","unstructured":"Aslan AT, Balaban HY. Hepatitis E virus: epidemiology, diagnosis, clinical manifestations, and treatment. World J Gastroenterol. 2020;26(37):5543\u201360.","journal-title":"World J Gastroenterol"},{"key":"2661_CR31","doi-asserted-by":"publisher","unstructured":"Xin S, Xiao L. Clinical Manifestations of Hepatitis E. In: Wang Y, editor. Hepatitis E virus. Dordrecht: Springer Netherlands; 2016 [cited 2025 May 28]. pp. 175\u201389. Available from: https:\/\/doi.org\/10.1007\/978-94-024-0942-0_10","DOI":"10.1007\/978-94-024-0942-0_10"},{"issue":"26","key":"2661_CR32","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1056\/NEJMra1208937","volume":"369","author":"W Bernal","year":"2013","unstructured":"Bernal W, Wendon J. Acute liver failure. N Engl J Med. 2013;369(26):2525\u201334.","journal-title":"N Engl J Med"},{"key":"2661_CR33","doi-asserted-by":"crossref","unstructured":"Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: a brief review. World J Hepatol. 2015;7(19):2194\u2013201.","DOI":"10.4254\/wjh.v7.i19.2194"},{"issue":"7","key":"2661_CR34","first-page":"607","volume":"61","author":"SA Chaudhry","year":"2015","unstructured":"Chaudhry SA, Verma N, Koren G. Hepatitis E infection during pregnancy. Can Fam Physician. 2015;61(7):607\u20138. PMID: 26175368; PMCID: PMC4501603.","journal-title":"Can Fam Physician"},{"issue":"1","key":"2661_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1477-5956-7-39","volume":"7","author":"S Taneja","year":"2009","unstructured":"Taneja S, Sen S, Gupta VK, Aggarwal R, Jameel S. Plasma and urine biomarkers in acute viral hepatitis E. Proteome Sci. 2009;7(1):39.","journal-title":"Proteome Sci"},{"issue":"1","key":"2661_CR36","doi-asserted-by":"publisher","first-page":"e0466422","DOI":"10.1128\/spectrum.04664-22","volume":"11","author":"MI Costafreda","year":"2023","unstructured":"Costafreda MI, Sauleda S, Riveiro-Barciela M, Rico A, Llorens-Revull M, Guix S, Pint\u00f3 RM, Bosch A, Rodr\u00edguez-Fr\u00edas F, Rando A, Piron M, Bes M. Specific plasma MicroRNA signatures underlying the clinical outcomes of hepatitis E virus infection. Microbiol Spectr. 2023;11(1):e0466422. https:\/\/doi.org\/10.1128\/spectrum.04664-22. Epub 2023 Jan 25. PMID: 36695578; PMCID: PMC9927377.","journal-title":"Microbiol Spectr"},{"issue":"10","key":"2661_CR37","doi-asserted-by":"publisher","first-page":"e13560","DOI":"10.1371\/journal.pone.0013560","volume":"5","author":"S Huang","year":"2010","unstructured":"Huang S, Zhang X, Jiang H, Yan Q, Ai X, Wang Y, Cai J, Jiang L, Wu T, Wang Z, Guan L, Kuo Shih JW, Ng H, Zhu F, Zhang J, Xia N. Profile of acute infectious markers in sporadic hepatitis E. PLoS ONE. 2010;5(10):e13560. https:\/\/doi.org\/10.1371\/journal.pone.0013560","journal-title":"PLoS ONE"},{"key":"2661_CR38","doi-asserted-by":"crossref","unstructured":"Copado-Villagrana ED, Pizuorno A, Garc\u00eda-Su\u00e1rez A, Abarca JC, DuPont G, Jaramillo-Bueno S et al. IL-18 discriminates highly frequent hepatitis E virus positive from negative blood donors in Mexico. Ann Hepatol. 2023. [cited 2025 May 27];28(5). Available from: http:\/\/www.elsevier.es\/en-revista-annals-hepatology-16-articulo-il-18-discriminates-highly-frequent-hepatitis-S1665268123002211","DOI":"10.1016\/j.aohep.2023.101117"},{"issue":"6","key":"2661_CR39","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","volume":"68","author":"EASL Clinical Practice Guidelines on hepatitis E virus infection","year":"2018","unstructured":"EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68(6):1256\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.005","journal-title":"J Hepatol"},{"issue":"5","key":"2661_CR40","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/microorganisms11051303","volume":"11","author":"S Takakusagi","year":"2023","unstructured":"Takakusagi S, Kakizaki S, Takagi H. The diagnosis, pathophysiology, and treatment of chronic hepatitis E virus infection\u2014a condition affecting immunocompromised patients. Microorganisms. 2023;11(5):1303.","journal-title":"Microorganisms"},{"issue":"5","key":"2661_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5501\/wjv.v12.i5.262","volume":"12","author":"H Iqbal","year":"2023","unstructured":"Iqbal H, Mehmood BF, Sohal A, Roytman M. Hepatitis E infection: a review. World J Virol. 2023;12(5):262.","journal-title":"World J Virol"},{"key":"2661_CR42","unstructured":"National Institute of Diabetes and Digestive and Kidney Diseases (US). LiverTox: clinical and research information on drug-induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"key":"2661_CR43","unstructured":"WHO Guidelines on GMP for Blood Establishments. Annex 4 (2023). https:\/\/www.who.int\/docs\/default-source\/medicines\/norms-and-standards\/guidelines\/production\/trs961-annex4-gmp-blood-establishments.pdf"},{"key":"2661_CR44","unstructured":"A method for developing a rapid immunochromatographic assay for identifying hepatitis E infection (ICMR-NIV HEV IgM Rapid Test). (Diagnostic Assay\/Kit). https:\/\/www.icmr.gov.in\/icmrobject\/custom_data\/1711646578_eoi05_mdms_extended.pdf"},{"issue":"12","key":"2661_CR45","doi-asserted-by":"publisher","first-page":"e70115","DOI":"10.1002\/jmv.70115","volume":"96","author":"Z Fan","year":"2024","unstructured":"Fan Z, Xu L, Cao Y, Liu T, Tian Y, Pan Z, Mo Y, Wang X, Zhu X, Gao Y, Zhang X, Pan CQ, Wang L, Ren F. One-pot assay based on CRISPR\/Cas13a technology for HEV RNA point-of-care testing. J Med Virol. 2024;96(12):e70115. https:\/\/doi.org\/10.1002\/jmv.70115. PMID: 39704190; PMCID: PMC11660031.","journal-title":"J Med Virol"},{"key":"2661_CR46","unstructured":"Development of a point of care lateral flow diagnostic to test for acute and past hepatitis E (Hev) In Saliva | National Agricultural Library. [cited 2025 Apr 9]. Available from: https:\/\/www.nal.usda.gov\/research-tools\/food-safety-research-projects\/development-point-care-lateral-flow-diagnostic-test"},{"key":"2661_CR47","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clinbiochem.2018.03.001","volume":"55","author":"D Ying","year":"2018","unstructured":"Ying D, Hong C, Wen G, Tang Z, Wang S, Zhang X, et al. Development and evaluation of a rapid point-of-care test for detecting the hepatitis E virus antigen. Clin Biochem. 2018;55:89\u201392.","journal-title":"Clin Biochem"},{"issue":"4","key":"2661_CR48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/10406387231167119","volume":"35","author":"M Li","year":"2023","unstructured":"Li M, Li T, Hao X, Liu Y, Lan H, Zhou C. Preliminary investigation of hepatitis E virus detection by a recombinase polymerase amplification assay combined with a lateral flow strip. J Veterinary Diagn Investigation: Official Publication Am Association Veterinary Lab Diagnosticians Inc. 2023;35(4):395\u20138. https:\/\/doi.org\/10.1177\/10406387231167119","journal-title":"J Veterinary Diagn Investigation: Official Publication Am Association Veterinary Lab Diagnosticians Inc"},{"issue":"4","key":"2661_CR49","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1177\/10406387231167119","volume":"35","author":"X Hao","year":"2023","unstructured":"Hao X, Liu Y, Lan H, Zhou C. Preliminary investigation of hepatitis E virus detection by a recombinase polymerase amplification assay combined with a lateral flow strip. J Veterinary Diagn Investigation: Official Publication Am Association Veterinary Lab Diagnosticians Inc. 2023;35(4):395\u20138. https:\/\/doi.org\/10.1177\/10406387231167119","journal-title":"J Veterinary Diagn Investigation: Official Publication Am Association Veterinary Lab Diagnosticians Inc"},{"key":"2661_CR50","doi-asserted-by":"publisher","unstructured":"Li M, He Q, Li T, Wan W, Zhou H. Development and evaluation of a CRISPR-Cas13a system-based diagnostic for hepatitis E virus. Clin Chem Lab Med. 2023;62(6):1237\u20131247. https:\/\/doi.org\/10.1515\/cclm-2023-1007. PMID: 38153113.","DOI":"10.1515\/cclm-2023-1007"},{"issue":"2","key":"2661_CR51","doi-asserted-by":"publisher","first-page":"e01064","DOI":"10.1128\/jcm.01064-24","volume":"63","author":"B Wei","year":"2025","unstructured":"Wei B, Wang W, Guo Z, Yin W, Cheng M, Yang Y, Tian Y, Sun Y, Liu T, Hu Y, She R. Rapid visual detection of hepatitis E virus combining reverse transcription recombinase-aided amplification with lateral flow dipstick and real-time fluorescence. J Clin Microbiol. 2025;63(2):e01064\u201324.","journal-title":"J Clin Microbiol"},{"key":"2661_CR52","doi-asserted-by":"crossref","unstructured":"Hui W, Wei L, Li Z, Guo X. Treatment of hepatitis E. Hepat E Virus. 2016;14:211\u201321.","DOI":"10.1007\/978-94-024-0942-0_12"},{"issue":"12","key":"2661_CR53","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","volume":"370","author":"N Kamar","year":"2014","unstructured":"Kamar N, Izopet J, Tripon S, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370(12):1111\u201320.","journal-title":"N Engl J Med"},{"issue":"1","key":"2661_CR54","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12879-020-05212-2","volume":"20","author":"I Ollivier-Hourmand","year":"2020","unstructured":"Ollivier-Hourmand I, Lebedel L, Lecouf A, Allaire M, Nguyen TTN, Lier C, Dao T. Pegylated interferon may be considered in chronic viral hepatitis E resistant to ribavirin in kidney transplant recipients. BMC Infect Dis. 2020;20(1):522. https:\/\/doi.org\/10.1186\/s12879-020-05212-2. PMID: 32677900; PMCID: PMC7367388.","journal-title":"BMC Infect Dis"},{"key":"2661_CR55","doi-asserted-by":"publisher","unstructured":"Lampejo T. Sofosbuvir in the treatment of hepatitis E virus infection: a review of in vitro and in vivo evidence. J Clin Exp Hepatol. 2022;12(4):1225\u201337. https:\/\/doi.org\/10.1016\/j.jceh.2022.02.003. Epub 2022 Feb 22. PMID: 35814503; PMCID: PMC9257862.","DOI":"10.1016\/j.jceh.2022.02.003"},{"issue":"21","key":"2661_CR56","doi-asserted-by":"publisher","first-page":"e00754","DOI":"10.1128\/JVI.00754-17","volume":"91","author":"N Kaushik","year":"2017","unstructured":"Kaushik N, Subramani C, Anang S, Muthumohan R, Shalimar, Nayak B, Ranjith-Kumar CT, Surjit M. Zinc salts block hepatitis E virus replication by inhibiting the activity of viral RNA-dependent RNA polymerase. J Virol. 2017;91(21):e00754\u201317. https:\/\/doi.org\/10.1128\/JVI.00754-17. PMID: 28814517; PMCID: PMC5640865.","journal-title":"J Virol"},{"issue":"11","key":"2661_CR57","doi-asserted-by":"publisher","first-page":"e0103524","DOI":"10.1128\/aac.01035-24","volume":"68","author":"M Kl\u00f6hn","year":"2024","unstructured":"Kl\u00f6hn M, G\u00f6mer A, He Q, Brown RJP, Todt D, Wang L, Steinmann E. The glutamate receptor antagonist ifenprodil inhibits hepatitis E virus infection. Antimicrob Agents Chemother. 2024;68(11):e0103524. https:\/\/doi.org\/10.1128\/aac.01035-24. Epub 2024 Oct 3. PMID: 39360823; PMCID: PMC11539220.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"2661_CR58","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.virs.2023.11.006","volume":"39","author":"H Guo","year":"2024","unstructured":"Guo H, Liu D, Liu K, Hou Y, Li C, Li Q, Ding X, Verstegen MMA, Zhang J, Wang L, Ding Y, Tang R, Pan X, Zheng K, van der Laan LJW, Pan Q, Wang W. Drug repurposing screen identifies vidofludimus calcium and pyrazofurin as novel chemical entities for the development of hepatitis E interventions. Virol Sin. 2024;39(1):123\u201333. Epub 2023 Nov 19. PMID: 37984761; PMCID: PMC10877426.","journal-title":"Virol Sin"},{"issue":"1","key":"2661_CR59","doi-asserted-by":"publisher","first-page":"2280500","DOI":"10.1080\/14756366.2023.2280500","volume":"38","author":"A Kumar","year":"2023","unstructured":"Kumar A, Hooda P, Puri A, Khatter R, Al-Dosari S, Sinha M, Parvez N, Sehgal MK. Methotrexate, an anti-inflammatory drug, inhibits hepatitis E viral replication. J Enzyme Inhib Med Chem. 2023;38(1):2280500. Epub 2023 Nov 17. PMID: 37975328; PMCID: PMC11003484.","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6","key":"2661_CR60","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/AAC.00003-19","volume":"63","author":"NE Netzler","year":"2019","unstructured":"Netzler NE, Enosi Tuipulotu D, Vasudevan SG, Mackenzie JM, White PA. Antiviral candidates for treating hepatitis E virus infection. Antimicrob Agents Chemother. 2019;63(6):e00003\u201319. https:\/\/doi.org\/10.1128\/AAC.00003-19. PMID: 30885901; PMCID: PMC6535575.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2661_CR61","doi-asserted-by":"publisher","first-page":"e15633","DOI":"10.1111\/liv.15633","volume":"45","author":"FS Larsen","year":"2025","unstructured":"Larsen FS, Saliba F. Liver support systems and liver transplantation in acute liver failure. Liver Int. 2025;45(3):e15633. https:\/\/doi.org\/10.1111\/liv.15633. Epub 2023 Jun 8. PMID: 37288706; PMCID: PMC11815598.","journal-title":"Liver Int"},{"key":"2661_CR62","doi-asserted-by":"crossref","unstructured":"Huang X, Lu J, Liao M, Huang Y, Wu T, Xia N. Progress and challenges to hepatitis E vaccine development and deployment. Vaccines. 2024;12(7):719.","DOI":"10.3390\/vaccines12070719"},{"issue":"10","key":"2661_CR63","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1080\/21645515.2016.1184806","volume":"12","author":"X Wu","year":"2016","unstructured":"Wu X, Chen P, Lin H, Hao X, Liang Z. Hepatitis E virus: current epidemiology and vaccine. Hum Vaccin Immunother. 2016;12(10):2603\u201310. https:\/\/doi.org\/10.1080\/21645515.2016.1184806. Epub 2016 May 16. PMID: 27184971; PMCID: PMC5085000.","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"2661_CR64","doi-asserted-by":"publisher","first-page":"e033702","DOI":"10.1136\/bmjopen-2019-033702","volume":"10","author":"K Zaman","year":"2020","unstructured":"Zaman K, Dudman S, Stene-Johansen K, Qadri F, Yunus M, Sandbu S, Gurley ES, Overbo J, Julin CH, Dembinski JL, Nahar Q. HEV study protocol: design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh. BMJ Open. 2020;10(1):e033702.","journal-title":"BMJ Open"},{"issue":"2","key":"2661_CR65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s00103-022-03487-1","volume":"65","author":"P Behrendt","year":"2022","unstructured":"Behrendt P, Wedemeyer H. Vaccines against hepatitis E virus: state of development. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(2):192\u2013201.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"2661_CR66","doi-asserted-by":"crossref","unstructured":"Ahmad T, Haroon H, Ahmad K, Shah SM, Shah MW, Hussain A et al. Hepatitis E vaccines: a mini review. Biomed Res Ther. 2021;8(9):4514\u201324.","DOI":"10.15419\/bmrat.v8i9.690"},{"issue":"2","key":"2661_CR67","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cmi.2024.11.016","volume":"31","author":"S Dudman","year":"2025","unstructured":"Dudman S, Zerja A, Hasano\u011flu \u0130, Ruta S, van Welzen B, Nicolini LA, et al. Global vaccination against hepatitis E virus: position paper from the European Society of Clinical Microbiology and Infectious Diseases Viral Hepatitis Study Group. Clin Microbiol Infect. 2025;31(2):201\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2661_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.virusres.2011.05.008","volume":"161","author":"S Kamili","year":"2011","unstructured":"Kamili S. Toward the development of a hepatitis E vaccine. Virus Res. 2011;161(1):93\u2013100.","journal-title":"Virus Res"},{"issue":"8","key":"2661_CR69","doi-asserted-by":"publisher","first-page":"826","DOI":"10.3390\/v12080826","volume":"12","author":"M Mazalovska","year":"2020","unstructured":"Mazalovska M, Kouokam JC. Progress in the production of virus-like particles for vaccination against hepatitis E virus. Viruses. 2020;12(8):826. https:\/\/doi.org\/10.3390\/v12080826. PMID: 32751441; PMCID: PMC7472025.","journal-title":"Viruses"},{"issue":"9","key":"2661_CR70","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1056\/NEJMoa061847","volume":"356","author":"MP Shrestha","year":"2007","unstructured":"Shrestha MP, Scott RM, Joshi DM, Mammen MP, Thapa GB, Thapa N, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med. 2007;356(9):895\u2013903.","journal-title":"N Engl J Med"},{"issue":"10","key":"2661_CR71","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1056\/NEJMoa1406011","volume":"372","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhang XF, Huang SJ, Wu T, Hu YM, Wang ZZ, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372(10):914\u201322.","journal-title":"N Engl J Med"},{"issue":"10429","key":"2661_CR72","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(23)02234-1","volume":"403","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang X, Su Y, Zhuang C, Tang Z, Huang X, et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomized, double-blind, placebo-controlled, phase 3 trial. Lancet Lond Engl. 2024;403(10429):813\u201323.","journal-title":"Lancet Lond Engl"},{"key":"2661_CR73","unstructured":"CTRI. [cited 2025 June 5]. Available from: https:\/\/www.ctri.nic.in\/Clinicaltrials\/pmaindet2.php?EncHid=ODAwMjg=%26;Enc=%26;userName=Adsorbed"},{"key":"2661_CR74","doi-asserted-by":"crossref","unstructured":"Cao YF, Tao H, Hu YM, Shi CB, Wu X, Liang Q et al. A phase 1 randomized open-label clinical study to evaluate the safety and tolerability of a novel Recombinant hepatitis E vaccine. Vaccine. 2017;35(37):5073\u201380.","DOI":"10.1016\/j.vaccine.2017.05.072"},{"issue":"9","key":"2661_CR75","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1016\/j.vaccine.2006.11.001","volume":"25","author":"C Dong","year":"2007","unstructured":"Dong C, Dai X, Meng JH. The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E. Vaccine. 2007;25(9):1662\u20138.","journal-title":"Vaccine"},{"issue":"4","key":"2661_CR76","doi-asserted-by":"publisher","first-page":"e0123400","DOI":"10.1371\/journal.pone.0123400","volume":"10","author":"Y Gao","year":"2015","unstructured":"Gao Y, Su Q, Yi Y, Jia Z, Wang H, Lu X, et al. Enhanced mucosal immune responses induced by a combined candidate mucosal vaccine based on hepatitis A virus and hepatitis E virus structural proteins linked to Tuftsin. PLoS ONE. 2015;10(4):e0123400.","journal-title":"PLoS ONE"},{"issue":"2","key":"2661_CR77","first-page":"78","volume":"19","author":"HZ Li","year":"2004","unstructured":"Li HZ, Gang HY, Sun QM, Liu X, Ma YB, Sun MS, Dai CB. Production in Pichia pastoris and characterization of genetic engineered chimeric HBV\/HEV virus-like particles. Chin Med Sci J. 2004;19(2):78\u201383. PMID: 15250239.","journal-title":"Chin Med Sci J"},{"issue":"4","key":"2661_CR78","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.vaccine.2013.11.064","volume":"32","author":"L Wang","year":"2014","unstructured":"Wang L, Cao D, Wei C, Meng XJ, Jiang X, Tan M. A dual vaccine candidate against norovirus and hepatitis E virus. Vaccine. 2014;32(4):445\u201352. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.064. Epub 2013 Nov 27. PMID: 24291540; PMCID: PMC3898346.","journal-title":"Vaccine"},{"issue":"11","key":"2661_CR79","doi-asserted-by":"publisher","first-page":"e40303","DOI":"10.5812\/jjm.40303","volume":"9","author":"M Makvandi","year":"2016","unstructured":"Makvandi M, Teimoori A, Neisi N, Samarbafzadeh A, Designing. Construction and expression of a recombinant fusion protein comprising the hepatitis E virus ORF2 and rotavirus NSP4 in the baculovirus expression system. Jundishapur J Microbiol. 2016;9(11):e40303. https:\/\/doi.org\/10.5812\/jjm.40303. PMID: 28138375; PMCID: PMC5240165.","journal-title":"Jundishapur J Microbiol"},{"key":"2661_CR80","doi-asserted-by":"publisher","first-page":"25735","DOI":"10.1038\/srep25735","volume":"6","author":"M Xia","year":"2016","unstructured":"Xia M, Wei C, Wang L, Cao D, Meng XJ, Jiang X, et al. Development and evaluation of two subunit vaccine candidates containing antigens of hepatitis E virus, rotavirus, and astrovirus. Sci Rep. 2016;6:25735.","journal-title":"Sci Rep"},{"issue":"12","key":"2661_CR81","doi-asserted-by":"publisher","first-page":"e0294663","DOI":"10.1371\/journal.pone.0294663","volume":"18","author":"T Anwar","year":"2023","unstructured":"Anwar T, Ismail S, Parvaiz F, Abbasi SW, Al-Abbasi FA, Alghamdi AM, et al. Computational design of experimentally validated multiepitopes vaccine against hepatitis E virus: an immunological approach. PLoS ONE. 2023;18(12):e0294663.","journal-title":"PLoS ONE"},{"issue":"3","key":"2661_CR82","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12602-019-09598-7","volume":"12","author":"LP Arce","year":"2020","unstructured":"Arce LP, Raya Tonetti MF, Raimondo MP, M\u00fcller MF, Salva S, \u00c1lvarez S, Baiker A, Villena J, Vizoso Pinto MG. Oral vaccination with hepatitis E virus capsid protein and immunobiotic bacterium-like particles induce intestinal and systemic immunity in mice. Probiotics Antimicrob Proteins. 2020;12(3):961\u201372.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"2661_CR83","doi-asserted-by":"publisher","first-page":"1512018","DOI":"10.3389\/fmicb.2024.1512018","volume":"15","author":"MF M\u00fcller","year":"2024","unstructured":"M\u00fcller MF, Sacur J, Brancher JM, Vera MD, Arce L, Raya-Tonetti MF, et al. An experimental chimeric hepatitis E virus vaccine elicits both local and systemic immune responses. Front Microbiol. 2024;15:1512018.","journal-title":"Front Microbiol"},{"key":"2661_CR84","doi-asserted-by":"publisher","unstructured":"Li T, Takeda N, Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine. 2001;19(25\u201326):3476-84. https:\/\/doi.org\/10.1016\/s0264-410x(01)00059-7. PMID: 11348714.","DOI":"10.1016\/s0264-410x(01)00059-7"},{"issue":"10","key":"2661_CR85","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3748\/wjg.v9.i10.2211","volume":"9","author":"Y Ma","year":"2003","unstructured":"Ma Y, Lin SQ, Gao Y, Li M, Luo WX, Zhang J, Xia NS. Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J Gastroenterol. 2003;9(10):2211\u20135. https:\/\/doi.org\/10.3748\/wjg.v9.i10.2211","journal-title":"World J Gastroenterol"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-025-02661-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-025-02661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:39:48Z","timestamp":1770021588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-025-02661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,16]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["2661"],"URL":"https:\/\/doi.org\/10.1007\/s15010-025-02661-2","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,16]]},"assertion":[{"value":"23 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the authors used ChatGPT (\n                      \n                      ) and Gemini (\n                      \n                      ) to generate the titles for the headings of the review article. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI and AI-assisted technologies in the writing process"}}]}}